Dyne Therapeutics, Inc. (DYN) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.92M | -19.2% |
| 2024 | $2.38M | +225.9% |
| 2023 | $729.0K | -76.2% |
| 2022 | $3.07M | -15.2% |
| 2021 | $3.62M | +211.6% |
| 2020 | $1.16M | -29.5% |
| 2019 | $1.65M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.92M | -19.2% |
| 2024 | $2.38M | +225.9% |
| 2023 | $729.0K | -76.2% |
| 2022 | $3.07M | -15.2% |
| 2021 | $3.62M | +211.6% |
| 2020 | $1.16M | -29.5% |
| 2019 | $1.65M | — |